Edition:
India

Insider Trading: Axcella Health Inc (AXLA.OQ)

AXLA.OQ on NASDAQ Stock Exchange Global Market

3.35USD
2:29am IST
Change (% chg)

$-0.21 (-5.90%)
Prev Close
$3.56
Open
$3.58
Day's High
$3.58
Day's Low
$3.34
Volume
12,953
Avg. Vol
3,237
52-wk High
$15.94
52-wk Low
$2.76

All Insider Trades
Trading Date Name Title Type Shares Traded Price
2 Aug 2019

Epstein (David R)

Director Buy 2,849 $7.04
1 Aug 2019

Epstein (David R)

Director Buy 4,092 $6.98
17 Jul 2019

Epstein (David R)

Director Buy 1,000 $7.55
10 Jul 2019

Epstein (David R)

Director Buy 1,322 $8.07
9 Jul 2019

Epstein (David R)

Director Buy 4,200 $8.24
8 Jul 2019

Epstein (David R)

Director Buy 274 $9.00
3 Jul 2019

Epstein (David R)

Director Buy 56 $8.99
2 Jul 2019

Epstein (David R)

Director Buy 3,500 $8.77
1 Jul 2019

Epstein (David R)

Director Buy 1,000 $8.74
28 Jun 2019

Epstein (David R)

Director Buy 5,400 $10.04
27 Jun 2019

Epstein (David R)

Director Buy 100 $9.15
26 Jun 2019

Epstein (David R)

Director Buy 14,500 $9.57
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 751,691 $0.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 335,457 $0.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 120,795 $0.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 503,840 $0.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 545,826 $0.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 48,602 $0.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 82,324 $0.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 486,023 $0.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 2,255,074 $0.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 194,409 $0.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 500,000 $20.00
13 May 2019

Flagship Ventures Fund IV General Partner L L C

Beneficial Owner of More than 10% Class Buy 209,933 $0.00

Institutional Holders

% Shares Owned: 62.47%
# of Holders: 48
Total Shares Held: 14,438,542
3 Mo. Net Change: 60,679
# New Positions: 9
# Closed Positions: 2
# Increased Positions: 19
# Reduced Positions: 19
# Net Buyers: 0

Officers & Directors

Name Age Since Current Position

William Hinshaw

President, Chief Executive Officer

Shane Maltbie

38 2019 Interim Principal Accounting Officer

Tony Tramontin

Senior Vice President of Research and Development , Chief Scientific Officer

Manu Chakravarthy

Senior Vice President of Clinical Development, Chief Medical Officer

Stephen Mitchener

Senior Vice President, chief Business Officer

Catherine Sohn

66 2019 Independent Director